5
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Second-trimester termination of pregnancy by extra-amniotic prostaglandin F2 α or endocervical misoprostol, A comparative study

&
Pages 429-432 | Published online: 07 Aug 2009

References

  • Robins J, Surrago EJ. Early midtrimester pregnancy termination. A comparison of dilatation and evacuation and intravaginal prostaglandin E2. J Reprod Med 1982; 27 (7): 415–19.
  • Jain JK, Mishell DR Jr. A comparison of intravaginal misoprostol with prostaglandin E2 for termination of second- trimester pregnancy. N Engl J Med 1994; 331(5): 290–3.
  • Thong KJ, Baird DT. Induction of second trimester abortion with mifepristone and gemeprost. Br J Obstet Gynaecol 1993; 100(8): 758–61.
  • Urquhart DR, Templeton AA. The use of mifepristone prior to prostaglandin induced mid-trimester termination. Hum Reprod 1990; 5: 883–6.
  • Rodger MW, Baird DT. Pretreatment with mifepristone (RU 486) reduces interval between prostaglandin administration and expulsion in second trimester abortion. Br J Obstet Gynaecol 1990; 97(1): 41–5.
  • Ho PC, Ma HK. Termination of second trimester pregnancy with sulprostone and mifepristone: a randomized double-blind placebo-controlled trial. Lancet 1993; 341 (8841): 321–3.
  • Peat B. Second trimester abortion by extra-amniotic PGF2 alpha infusion: experience of 178 cases. Aust N Z J Obstet Gynaecol 1991 Feb; 31(1): 47–51.
  • Ferguson JE 2d, Burkett BJ, Pinkerton JV, Thiagarajah S, Flather MM, Martel MM et al. Intraamniotic 15(s)-15-methyl prostaglandin F2 alpha and termination of middle and late second-trimester pregnancy for genetic indications: a contemporary approach. Am J Obstet Gynecol 1993; 169(2(1)): 332–9.
  • Hinshaw K, El-Rafaey H, Rispin R, Templeton AA. Midtrimester termination for fetal abnormality: advantages of a new regimen using mifepristone and misoprostol. Br J Obstet Gynaecol 1995; 102: 559–60.
  • Kaltreider NB, Goldsmith S, Margolis AJ. The impact of midtrimester abortion techniques on patients and staff. Am J Obstet Gynecol 1979; 135: 235–8.
  • Jaschevatzky OE, Leiserowitz DM, Miller M, Grunstein S. Extraamniotic infusion of prostaglandin F2 alpha in normal saline for termination of midtrimester missed abortion. Eur J Obstet Gynecol Reprod Biol 1983 Jul; 15(3): 185–7.
  • Smith DH, Dalrymple JC. A comparison of intraamniotic prostaglandin and extraamniotic prostaglandin gel for midtrimester termination of pregnancy. Aust N Z J Obstet Gynaecol 1983 Feb; 23(1): 32–4.
  • Gruber W. Prostaglandins for the termination of pathological pregnancies in the 2nd trimester. Wien Klin Wochenschr 1982 Oct 29; 94(20): 558–60.
  • Lehair J, Lemarie P, Helleringer M, Manini P. Expulsion of arrested pregnancy product in the second trimester using a prostaglandin E1 analog administered intravaginally. Apropos of 12 cases. Rev Fr Gynecol Obstet 1989; 84(1): 19–23.
  • Bugalho A, Bique C, Almeida L, Bergstrom S. Pregnancy interruption by vaginal misoprostol. Gynecol Obstet Invest 1993; 36(4): 226–9.
  • Merrell DA, Koch MA. Induction of labour with intravaginal misoprostol in the second and third trimesters of pregnancy. S Afr Med J 1995; 85(10 Suppl): 1088–90.
  • Yapar EG, Senoz S, Urkutur M, Batioglu S, Gokmen O. Second trimester pregnancy termination including fetal death: comparison of five different methods. Eur J Obstet Gynecol Reprod Biol 1996; 69(2): 97–102.
  • Jain JK, Mishell DR Jr. A comparison of misoprostol with and without laminaria tents for induction of second-trimester abortion. Am J Obstet Gynecol 1996; 175(1): 173–7.
  • El-Refaey H, Templeton A. Induction of abortion in the second trimester by a combination of misoprostol and mifepristone: a randomized comparison between two misoprostol regimens. Hum Reprod 1995; 10(2): 475–8.
  • Webster D, Penney GC, Templeton A. A comparison of 600 and 200 mg mifepristone prior to second trimester abortion with the prostaglandin misoprostol. Br J Obstet Gynaecol 1996; 103: 706–9.
  • Bugalho A, Bique C, Almeida L, Faundes A. The effectiveness of intravaginal misoprostol (Cytotec) in inducing abortion after eleven weeks of pregnancy. Stud Fam Plann 1993; 24(5): 319–23.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.